Global Medical REIT Inc (NYSE:GMRE) has been assigned an average rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $10.20.
A number of equities research analysts have commented on GMRE shares. Zacks Investment Research cut Global Medical REIT from a “hold” rating to a “sell” rating in a report on Tuesday, November 7th. B. Riley reissued a “buy” rating on shares of Global Medical REIT in a report on Wednesday, November 1st. Finally, TheStreet cut Global Medical REIT from a “c-” rating to a “d” rating in a report on Thursday, February 1st.
Shares of Global Medical REIT (NYSE GMRE) opened at $7.20 on Wednesday. The company has a current ratio of 0.22, a quick ratio of 0.22 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $155.74, a PE ratio of -36.00, a price-to-earnings-growth ratio of 1.15 and a beta of -41.48. Global Medical REIT has a twelve month low of $6.84 and a twelve month high of $10.25.
About Global Medical REIT
Global Medical REIT Inc is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.